Compare CREG & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CREG | HIND |
|---|---|---|
| Founded | N/A | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.1M | 28.0M |
| IPO Year | N/A | 2016 |
| Metric | CREG | HIND |
|---|---|---|
| Price | $1.20 | $3.26 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 87.0K | N/A |
| Earning Date | 02-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $173,659.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.93 | N/A |
| 52 Week High | $14.70 | N/A |
| Indicator | CREG | HIND |
|---|---|---|
| Relative Strength Index (RSI) | 45.13 | 44.57 |
| Support Level | $1.16 | $3.00 |
| Resistance Level | $1.34 | $3.25 |
| Average True Range (ATR) | 0.12 | 0.34 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 19.34 | 47.18 |
Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.
Vyome Holdings Inc is a reseach and development company. The Company operates in two segments, biotechnology and pharmaceutical products. The biotechnology segment comprises of operations around VT-1953, VT-1908, and VB-1953 programs that are in development, and the pharmaceutical segment comprises of antifungal products manufacturing and distribution.